| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/15/2011 | CN101445528B Sulpho-glucosan derivative and preparation method and application thereof |
| 06/15/2011 | CN101381366B Benzimidazole derivative and its use as a ii receptor antagonist |
| 06/15/2011 | CN101342205B Traditional Chinese medicine preparation for decreasing blood fat |
| 06/15/2011 | CN101253171B Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 06/15/2011 | CN101223937B Edible pet quid containing nutrition rod and preparing method thereof |
| 06/15/2011 | CN101218246B Improved crystalline form of compound A-348441 |
| 06/15/2011 | CN101204418B Application of Cajanus cajan L. extracts on preparating hyperlipemia medicine |
| 06/15/2011 | CN101167973B Traditional Chinese medicine for treating hyperlipemia |
| 06/15/2011 | CN101166545B Glp-1 pegylated compounds |
| 06/15/2011 | CN101137660B Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 06/15/2011 | CN101130770B Nucleotide molecule SR2B and application of the same in producing antidiabetic medicament |
| 06/15/2011 | CN101130769B Nucleotide molecule SR4B and application of the same in producing antidiabetic medicament |
| 06/15/2011 | CN101094847B Aryloxy-substituted benzimidazole derivatives |
| 06/15/2011 | CA2709095A1 Compositions and methods for controlling blood glucose levels |
| 06/14/2011 | USRE42461 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 06/14/2011 | US7960433 Treatment of chemokine mediated diseases |
| 06/14/2011 | US7960416 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization |
| 06/14/2011 | US7960412 Selective estrogen receptor modulator |
| 06/14/2011 | US7960394 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders |
| 06/14/2011 | US7960369 Receptor function regulator |
| 06/14/2011 | US7960367 Pregnane steroids and their use in the treatment of CNS disorders |
| 06/14/2011 | US7960341 Methods and compositions for treating polycystic ovary syndrome |
| 06/14/2011 | US7960102 Regulated aptamer therapeutics |
| 06/14/2011 | US7959956 Method for treating diabetic complications |
| 06/14/2011 | CA2494962C Tyrosine kinase inhibitors |
| 06/14/2011 | CA2480987C Natural products and derivatives thereof for protection against neurodegenerative diseases |
| 06/14/2011 | CA2470037C Prodrugs to d-prolines |
| 06/14/2011 | CA2461614C Mixture of base-containing micronutrient substances |
| 06/14/2011 | CA2445322C Use of the abc expression promoting agent pioglitazone for the treatment of arteriosclerosis obliterans |
| 06/14/2011 | CA2443325C Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 06/14/2011 | CA2436421C Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same |
| 06/14/2011 | CA2433667C Prodrugs of excitatory amino acids |
| 06/14/2011 | CA2430669C Synthesis of 3-amino-thalidomide and its enantiomers |
| 06/14/2011 | CA2428468C New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 06/14/2011 | CA2426292C Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 06/14/2011 | CA2425311C Ketone compounds and compositions for cholesterol management and related uses |
| 06/14/2011 | CA2369591C Disodium salts, monohydrate, and ethanol solvates |
| 06/14/2011 | CA2338419C Pulmonary delivery of active agents |
| 06/14/2011 | CA2222630C Material inhibiting lipid peroxide-increase |
| 06/09/2011 | WO2011069038A2 Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| 06/09/2011 | WO2011068703A2 Methods of modulating inflammation in preterm infants using carotenoids |
| 06/09/2011 | WO2011068211A1 2-pyridone compounds |
| 06/09/2011 | WO2011068171A1 Bicyclic nitrogen-containing saturated heterocyclic derivatives |
| 06/09/2011 | WO2011068150A1 Glucagon-like peptide-1 secretion enhancer |
| 06/09/2011 | WO2011068149A1 Cholecystokinin secretion enhancer |
| 06/09/2011 | WO2011067174A1 Aniline analogs as glycogen synthase activators |
| 06/09/2011 | WO2011067166A1 Azacyclic spiro derivatives |
| 06/09/2011 | WO2011066659A1 Method of regulating ppar, obesity related pathways and their associated metabolic impact |
| 06/09/2011 | WO2011066653A1 Salacinol and ponkoranol homologues, derivatives thereof, and methods of synthesizing same |
| 06/09/2011 | WO2011066614A1 Liquid compositions comprising vitamin d and uses thereof |
| 06/09/2011 | WO2011014661A3 Liver x receptor agonists |
| 06/09/2011 | US20110136917 Tetrahydro-isoalpha acid compositions and methods for weight management |
| 06/09/2011 | US20110136914 Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity |
| 06/09/2011 | US20110136911 Treatment of sepsis and inhibition of mif by d-t4 |
| 06/09/2011 | US20110136909 Method for suppressing excessive appetite |
| 06/09/2011 | US20110136906 Use of hydroxyoleic acid and related compounds in the manufacture of drugs |
| 06/09/2011 | US20110136905 Crystalline teglicar |
| 06/09/2011 | US20110136889 Compositions and their uses directed to aceytl-coa carboxylases |
| 06/09/2011 | US20110136888 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof |
| 06/09/2011 | US20110136881 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents |
| 06/09/2011 | US20110136871 2-alkoxy-substituted dicyanopyridines and their use |
| 06/09/2011 | US20110136856 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 06/09/2011 | US20110136853 Ligand with a broad spectrum of pharmacological activity, a pharmaceutical composition, a medicinal agent and a method of treatment |
| 06/09/2011 | US20110136828 Substituted n-oxide pyrazine derivatives |
| 06/09/2011 | US20110136821 Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase Type 1 |
| 06/09/2011 | US20110136817 Methods of identifying responders to dopamine agonist therapy |
| 06/09/2011 | US20110136814 Diazepine and Diazocane Compounds As MC4 Agonists |
| 06/09/2011 | US20110136813 Wnt protein signalling inhibitors |
| 06/09/2011 | US20110136808 3',6-substituted indirubins and their biological applications |
| 06/09/2011 | US20110136807 Bicyclic compositions and methods for modulating a kinase cascade |
| 06/09/2011 | US20110136800 Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
| 06/09/2011 | US20110136797 Cyclopropyl amines as modulators of the histamine h3 receptor |
| 06/09/2011 | US20110136792 Novel carboxylic acid analogs as glycogen synthase activators |
| 06/09/2011 | US20110136790 Tricyclic Heterocyclic Derivatives and Methods of Use |
| 06/09/2011 | US20110136789 C-met protein kinase inhibitors |
| 06/09/2011 | US20110136783 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| 06/09/2011 | US20110136767 Processes for preparing piperazinium salts of kmup and use thereof |
| 06/09/2011 | US20110136765 Pyrrolo[2,3-D]Pyrimidine Compounds |
| 06/09/2011 | US20110136746 Kallikrein-Binding "Kunitz Domain" Proteins and Analogues Thereof |
| 06/09/2011 | US20110136737 DPP-IV Resistant GIP Hybrid Polypeptides with Selectable Properties |
| 06/09/2011 | US20110136736 New insulin analogues of prolonged activity |
| 06/09/2011 | US20110136735 Cyclohexane derivatives and uses thereof |
| 06/09/2011 | US20110136734 Methods of Modulating Inflammation in Preterm Infants Using Carotenoids |
| 06/09/2011 | US20110136733 Analogues of glucose-dependent insulinotropic polypeptide |
| 06/09/2011 | US20110136732 Infant nutritional compositions for preventing obesity |
| 06/09/2011 | US20110136728 Methods of increasing bone formation using leptin-related peptides |
| 06/09/2011 | US20110136725 Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal |
| 06/09/2011 | US20110136724 Analogues of glucose-dependent insulinotropic polypeptide |
| 06/09/2011 | US20110135768 Dihydro-isoalpha acid and acacia nilotica extract based compositions and methods for weight management |
| 06/09/2011 | US20110135762 Composition comprising 1,3/1 6 beta glucan for reducing weight |
| 06/09/2011 | US20110135732 Multiple phase cross-linked compositions and uses thereof |
| 06/09/2011 | US20110135727 Hepatocyte Delivery Vehicle for Delivery of a Combination of Recombinant Human Regular Insulin and Recombinant Human Insulin Isophane to a Mammal |
| 06/09/2011 | US20110135725 Lipid Construct for Delivery of Insulin to a Mammal |
| 06/09/2011 | US20110135717 Composition for Prevention or Treatment of Hyperlipidemia, Fatty Liver or Obesity |
| 06/09/2011 | US20110135708 Dietary supplement - liquid filled gum |
| 06/09/2011 | US20110135695 Oral dosage form for controlled drug release |
| 06/09/2011 | US20110135681 Composition and Method for Enhancing Insulin Activity |
| 06/09/2011 | US20110135678 Tolerizing agents |
| 06/09/2011 | US20110135657 Human antigen binding proteins that bind beta-klotho, fgf receptors and complexes thereof |
| 06/09/2011 | US20110135632 Methods for the modulation of angiogenesis |